Cargando…
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
The safety and effectiveness of tetrabenazine in different sub-populations of Huntington disease (HD) is not known. In this study, we evaluated the safety of tetrabenazine in individuals on an antidepressant and its effectiveness in advanced HD. Tetrabenazine was not associated with an increased inc...
Autores principales: | Dorsey, Ray, Biglan, Kevin, Eberly, Shirley, Auinger, Peggy, Brocht, Alicia, Umeh, Chizoba C., Oakes, David, Clarence-Smith, Kathleen, Marshall, Frederick, Shoulson, Ira, Frank, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216756/ https://www.ncbi.nlm.nih.gov/pubmed/22139861 http://dx.doi.org/10.1371/currents.RRN1283 |
Ejemplares similares
-
Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011) -
Evaluation of Histone Deacetylases as Drug Targets in Huntington’s Disease models: Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.
por: Quinti, Luisa, et al.
Publicado: (2010) -
Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011) -
Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011) -
Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington Disease
por: Aylward, Elizabeth, et al.
Publicado: (2011)